Sanofi Seeks Certiorari Over Change Of Law Forfeiture, Patent Obviousness Standard
WASHINGTON, D.C. — In a June 26 petition for certiorari in the U.S. Supreme Court, pharmaceutical firm Sanofi-Aventis Deutschland GMBH seeks review of two areas in patent law: the application or...To view the full article, register now.
Already a subscriber? Click here to view full article